Afrigen

09/03/2026

🔹 From cancer tests to COVID vaccines: the women reshaping Europe’s health in a male-dominated field 🔹

Women Innovators in Science: Progress Made, but the Gender Gap Remains

⏭️ Read more here: https://www.msn.com/en-sg/news/other/from-cancer-tests-to-covid-vaccines-the-women-reshaping-europe-s-health-in-a-male-dominated-field/ar-AA1XKyES

Despite a surge in female scientists across the continent, women account for just 13 percent of European inventors. View on euronews

15/02/2026

🔹 Congratulations to Vathi one of our Board Members. 🔹

Clevenard to Honour Dr. Vathi Papu-Zamxaka!

Clevenard SL is proud to announce that Dr. Vathi Papu-Zamxaka, Deputy Vice-Chancellor: Research, Innovation & Engagement at Tshwane University of Technology (TUT), South Africa, will be honoured with a prestigious Honorary Award at the Clevenard Open Project 2026 in Alicante, Spain!

Dr. Papu-Zamxaka is a visionary leader, award-winning scientist, and one of Africa’s most influential voices in research, innovation, and higher education. She has transformed TUT into a global hub for innovation, AI, and entrepreneurship, expanded research outputs, and established international partnerships to prepare students for the future of work.

She will also deliver a keynote address on Day 1 (27 August) at the Global Authors’ Recognition & Education Summit, sharing insights on “Science, Innovation & the Future of Global Education.”

Join us in celebrating her remarkable achievements and inspiring leadership at !

📅 Dates: 27–30 August 2026 | Alicante, Spain

15/02/2026

🔹 Congratulations to Vathi one of our Board Members. 🔹

Clevenard to Honour Dr. Vathi Papu-Zamxaka!

Clevenard SL is proud to announce that Dr. Vathi Papu-Zamxaka, Deputy Vice-Chancellor: Research, Innovation & Engagement at Tshwane University of Technology (TUT), South Africa, will be honoured with a prestigious Honorary Award at the Clevenard Open Project 2026 in Alicante, Spain!

Dr. Papu-Zamxaka is a visionary leader, award-winning scientist, and one of Africa’s most influential voices in research, innovation, and higher education. She has transformed TUT into a global hub for innovation, AI, and entrepreneurship, expanded research outputs, and established international partnerships to prepare students for the future of work.

She will also deliver a keynote address on Day 1 (27 August) at the Global Authors’ Recognition & Education Summit, sharing insights on “Science, Innovation & the Future of Global Education.”

Join us in celebrating her remarkable achievements and inspiring leadership at hashtag !

📅 Dates: 27–30 August 2026 | Alicante, Spain

25/12/2025

🔹🎄🔹

17/12/2025

Thermo Fisher Scientific Expands Gibco™ Bacto™ Portfolio with Next-Generation, Chemically Defined Media to Boost E. coli Biomanufacturing Productivity

New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence

Read more here: https://www.businesswire.com/news/home/20251215212298/en/Thermo-Fisher-Scientific-Expands-Gibco-Bacto-Portfolio-with-Next-Generation-Chemically-Defined-Media-to-Boost-E.-coli-Biomanufacturing-Productivity

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco™ Bacto™ CD Supreme FPM Plus and Gibco™ Bacto™ CD Supr...

11/12/2025

🔹 Quantoom Biosciences and Afrigen Biologics Complete First Technical Production Run of mRNA Vaccine Against Rift Valley Fever

🔹Milestone advances rapid-response vaccine capability for an emerging climate-sensitive threat.

📍 Brussels, Belgium & Cape Town, South Africa — 11 December 2025

Quantoom Biosciences and Afrigen Biologics (Pty) Ltd today announced the successful completion of a technical production run (800ml IVT) for an mRNA-based vaccine candidate targeting Rift Valley fever (RVF) — marking a major step toward developing the first human vaccine against a disease that poses growing epidemic risks across Africa and the Middle East.

Read more ⏭️ https://lnkd.in/ddvF_eKY

Technology Transfer Programme

04/12/2025

🔹Afrigen Biologics (Pty) Ltd proudly welcomed our colleagues from Kenya BioVax Institute Limited in collaboration with Kenya Medical Research Institute (KEMRI), mRNA Technology Transfer Programme Kenyan partner, for their 3- week intensive training as part of the technology transfer demonstration activities in Nov/Dec 2025. This included manufacturing drug substance and manufacturing drug product, each at 100 mL scale, and associated analytics. 🔹

📸 #1 Showing their final bulk product manufactured and tested at Afrigen.

Medicines Patent Pool

World Health Organization

24/11/2025

🔹 is building — and the world is building with us 🔹

Our responsible pharmacist, Lyzelle Woldson, represented Afrigen Biologics (Pty) Ltd Biologics at the inaugural Pharmacovigilance Training Workshop hosted by CEPSA at the University of the Western Cape, in collaboration with Africa CDC and partners at Institute of Tropical Medicine (ITM), Antwerp.

⏭️ Strengthening patient safety systems is how we enable innovation, build confidence in locally manufactured vaccines and biologics, and advance Africa’s health sovereignty.

🤝 Together, we create a safer world for everyone.

This is the spirit of ubuntu — capacity and capability built together. 💪

21/11/2025

🔹 Afrigen Biologics (Pty) Ltd was delighted to host distinguished delegates from Merck Life Sciences, Merck Healthcare & E. Merck KG. We are proud and grateful for the support and collaboration. 🔹

🔬 🥼

17/11/2025

🔹 Afrigen proudly welcomed our colleagues from Polyvac, mRNA Technology Transfer Programme Vietnamese partner, for their 3- week intensive training as part of the technology transfer demonstration activities in October 2025. This included manufacturing drug substance and manufacturing drug product, each at 100 mL scale, and associated analytics. 🔹

📸 #1 Showing their final bulk product manufactured and tested at Afrigen Biologics (Pty) Ltd.


Medicines Patent Pool

World Health Organization

Ngo Thu

💻 http://polyvac.com.vn/ #

14/11/2025

🔹 This past week, Afrigen Biologics (Pty) Ltd proudly hosted the first cohort participants of the Africa CDC Biomanufacturing Fellowship Programme at our facilities. As a member of the Southern African Regional Capability and Capacity Network (SA-RCCN), established by Africa CDC, we welcomed five fellows with diverse expertise that enriched discussions throughout the sessions.

🔬 The fellows were introduced to Afrigen’s end-to-end vaccine capabilities, spanning research and development, technology transfer within our CMC team, production, quality control and assurance, supply chain, engineering, validation, and skills development. These interactions were insightful and fostered mutual learning between the fellows and Afrigen teams.

⏭️ We wish the fellows success in the remainder of their programme and look forward to seeing them emerge as future leaders in across Africa.


MWANGI ALEX Dr Anna SECK Tendai Mabhumbo Ahmed Youssef Hanâ Baba Dr Vetja Haakuria Prof Zakaria Belrhiti

13/11/2025

🔬At the G20 Health Ministers' Meeting in South Africa 🇿🇦

The past week, Afrigen Biologics (Pty) Ltd had the honour of joining global health leaders in Polokwane at the G20 Health Ministers' Meeting in Polokwane, where the mRNA Technology Transfer Programme was proudly showcased.

Our team engaged with delegates from around the world to highlight what African-led science and biomanufacturing looks like in action. From a modest lab to a fully integrated end -to-end mRNA R&D and manufacturing platform, our journey reflects the very purpose of this Programme: to build capabilities where they are most needed — in the Global South, for the Global South.

We are proud to be part of a network driving equity, innovation, and regional resilience. This is not just about pandemic preparedness — it's about building sustainable health systems rooted in local expertise, local talent, and local solutions.

🧬 Here's to African science on the global stage.